Showing results (291-300 of 529) with videos related to

Sort By:
Pageof 53
Schizophrenia (Heidelberg, Germany)|October 30, 2022
Impaired dynamic functional brain properties and their relationship to symptoms in never treated first-episode patients with schizophreniaWanfang You, Lekai Luo, Li Yao, et al.
Schizophrenia (Heidelberg, Germany)|August 29, 2025
What is behind the 17-year life expectancy gap between individuals with schizophrenia and the general population?Andreea-Violeta Popa, Petru Iulian Ifteni, Daniel Țâbian, et al.
Schizophrenia (Heidelberg, Germany)|August 20, 2022
Evidence for the contribution of HCN1 gene polymorphism (rs1501357) to working memory at both behavioral and neural levels in schizophrenia patients and healthy controlsXiongying Chen, Qiumei Zhang, Yanyan Su, et al.
Schizophrenia (Heidelberg, Germany)|August 4, 2022
Extrapyramidal symptoms predict cognitive performance after first-episode psychosisMaija Lindgren, Sebastian Therman, Anna Avellan, et al.
Schizophrenia (Heidelberg, Germany)|November 7, 2022
Identifying psychiatric manifestations in schizophrenia and depression from audio-visual behavioural indicators through a machine-learning approachShihao Xu, Zixu Yang, Debsubhra Chakraborty, et al.
Schizophrenia (Heidelberg, Germany)|November 12, 2022
Disengagement from early psychosis intervention services: an observational study informed by a survey of patient and family perspectivesAlexia Polillo, Aristotle N Voineskos, George Foussias, et al.
Schizophrenia (Heidelberg, Germany)|November 13, 2022
Language abnormalities in schizophrenia: binding core symptoms through contemporary empirical evidenceXiao Chang, Wei Zhao, Jujiao Kang, et al.
Schizophrenia (Heidelberg, Germany)|December 3, 2022
Safety and tolerability of KarXT (xanomeline-trospium) in a phase 2, randomized, double-blind, placebo-controlled study in patients with schizophreniaChristoph U Correll, Angel S Angelov, Andrew C Miller, et al.
Schizophrenia (Heidelberg, Germany)|December 29, 2022
Metabolic contributions to neuronal deficits caused by genomic disruption of schizophrenia risk gene SETD1AZheng-Shan Chong, Zi Jian Khong, Shermaine Huiping Tay, et al.
Schizophrenia (Heidelberg, Germany)|May 26, 2023
Real-world effectiveness of antidepressant use in persons with schizophrenia: within-individual study of 61,889 subjectsArto Puranen, Marjaana Koponen, Markku Lähteenvuo, et al.
Pageof 53